Company Filing History:
Years Active: 2005
Title: Teruhiko Nitoda: Innovator in Cell Division Inhibition
Introduction
Teruhiko Nitoda is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of cell division inhibitors. His work is essential for advancing medical research and therapeutic applications.
Latest Patents
Nitoda holds a patent for a cell division inhibitor and its production method. The patent describes a cell division inhibitor that comprises various dehydrodiketopiperazines, such as dehydrophenylahistin, or analogs thereof, as an active ingredient. Additionally, it includes a dehydrogenase and a method for producing the same inhibitor. This innovation has the potential to impact various medical treatments.
Career Highlights
Teruhiko Nitoda is associated with Nereus Pharmaceuticals, Inc., where he continues to work on groundbreaking research. His expertise in biotechnology and patentable inventions has positioned him as a key figure in his field. With a focus on developing effective inhibitors, he contributes to the advancement of therapeutic solutions.
Collaborations
Nitoda collaborates with esteemed colleagues, including Hiroshi Kanzaki and Kaneo Kanoh. Their combined efforts enhance the research and development process, leading to innovative solutions in biotechnology.
Conclusion
Teruhiko Nitoda's work in cell division inhibition exemplifies the importance of innovation in biotechnology. His contributions, including his patent and collaborations, highlight his role as a significant inventor in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.